XML 93 R46.htm IDEA: XBRL DOCUMENT v3.22.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows from Operating Activities:    
Net (loss) income $ (806,222) $ 1,328,853
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Interest earned on investments held in Trust Account (1,955) (19,421)
Change in fair value of warrant liability 410,400 (4,104,000)
Loss on initial issuance of warrant liability   2,599,200
Change in fair value of conversion option liability 69,896  
Amortization of debt discount 7,466  
Transaction costs allocated to private warrants   30,212
Changes in operating assets and liabilities:    
Prepaid expenses (392,365) (346,386)
Accounts payable and accrued expenses (167,701) 17,210
Net cash used in operating activities (880,481) (494,332)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (1,035,000) (139,380,000)
Net cash used in investing activities (1,035,000) (139,380,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid   135,600,000
Proceeds from sale of Private Placement Warrants   5,130,000
Advances from related party   25,000
Repayment of advances from related party   (55,000)
Proceeds from promissory note - related party 1,535,000  
Repayment of promissory note - related party   (125,000)
Payment of offering costs   (416,260)
Net cash provided by financing activities 1,535,000 140,158,740
Net Change in Cash (380,481) 284,408
Cash - Beginning of period 507,921 30,511
Cash - End of period $ 127,440 314,919
Non-Cash investing and financing activities:    
Deferred underwriting fee payable   $ 5,190,000